 WATERTOWN, Mass., Aug. 03, 2022 GLOBE NEWSWIRE -- Werewolf Therapeutics, Inc. the Company or Werewolf Nasdaq: HOWL, an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the bodys immune system for the treatment of cancer, today announced that management will participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference being held from August 9-10, 2022. 